Design, synthesis, and apoptotic antiproliferative efficacy of new quinazoline/1,3,4-oxadiazole-2-thione derived EGFR/HER-2 dual inhibitors with anti-breast cancer activity
- 10 July 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (9) , 4297-4315
Abstract
A series of new multi-target inhibitors derived from quinazoline and 1,3,4-oxadiazole-2-thione were designed, synthesized, and tested in vitro for their antiproliferative efficacy.Keywords
Funding Information
- Al Jouf University (DGSSR-2024-01-02042)
- Karlsruhe Institute of Technology
This publication has 56 references indexed in Scilit:
- Advances in synthesis and biological activities of quinazoline scaffold analogues: A reviewArabian Journal of Chemistry, 2023
- Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationshipBioorganic Chemistry, 2023
- New 1,3,4‐oxadiazole‐chalcone/benzimidazole hybrids as potent antiproliferative agentsArchiv der Pharmazie, 2022
- New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinaseArchiv der Pharmazie, 2022
- Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activitiesBioorganic Chemistry, 2022
- Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IVBioorganic Chemistry, 2021
- Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluationBioorganic Chemistry, 2020
- Anticancer activities of novel Mannich bases against prostate cancer cellsMedicinal Chemistry Research, 2019
- Synthesis of some novel 3,5-disubstituted 1,3,4-oxadiazole derivatives and anticancer activity on EAC animal modelMedicinal Chemistry Research, 2010
- Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: Promising anticancer agentsBioorganic & Medicinal Chemistry, 2006